(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Record-Breaking Weight Loss in Trials Triple Hormone Targeting Rapid Fat Loss in the First Months Visceral Fat Meltdown Improves Insulin Sensitivity in a Big Way Longevity Potential Appetite Control That Actually Lasts All Day Possible Anti-Fibrotic & Liver Benefits Certificate Of Analysis by 3rd Party Lab When it comes to peptides, independent verification matters
Our team customizes each treatment plan, and well cover all pricing and financing options during your consultation
Its potent formulation is particularly effective for those struggling with hyperpigmentation and uneven skin tone, providing a reliable solution for achieving a clear and radiant complexion